Maximising data capture in obesity trials
Global obesity trials are scaling fast with GLP‑1 therapies, making complete data capture essential to preserve scientific integrity and timelines.…
Global obesity trials are scaling fast with GLP‑1 therapies, making complete data capture essential to preserve scientific integrity and timelines.…
This is the first episode in our second season exploring the evolving landscape of real-world data and its role in…
Pharmaceutical third-party logistics (3PL) providers are moving beyond traditional warehousing into more holistic and strategic commercialization support. At the same…
As oncology therapies mature, post-approval research is essential to supporting regulatory commitments, label expansion, and real-world adoption—often under tight timelines.…
As clinical trials become more digitalised, the data landscape is expanding faster than the processes designed to control it. Electronic…
Israel has a robust and growing clinical trials ecosystem. This podcast explores the factors that what make Israel such an…
Each year in the US, more than 21,000 women will receive a new diagnosis of ovarian cancer according to the…
Nephrology has long been a difficult space for drug development: trials were slow, complex, high cost, and often unrewarding, constrained…
As clinical trial protocols grow more complex, so does the burden on research sites managing data collection and entry. Manual…
As requirements shift toward more complex, value-added solid formats and iAs requirements shift toward more complex, value-added solid formats and…